Cohen 2019.
Study characteristics | ||
Methods | Multicentre prospective cohort study. Study period 2014 to 2017. | |
Participants | Country: USA. Crohn's and ulcerative colitis patients undergoing intra‐abdominal surgery. | |
Interventions | 1. Preoperative anti‐TNF therapy (n= 382) within 12 weeks of surgery. 2. No preoperative anti‐TNF exposure (n= 573) |
|
Outcomes | 30 post operative infectious complications (any infection and surgical site infection) | |
Notes | NOS low risk of bias overall Adjusted OR for preoperative anti‐TNF therapy was obtained from m ultivariable logistic regression model. |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Representativeness of the exposed cohort | Low risk | Prospective cohort of IBD patients who underwent intra‐abdominal surgery from 2014 to 2017 |
Selection of the non exposed cohort | Low risk | Both groups obtained from same centres and time period |
Ascertainment of exposure | Low risk | Prospective database. Data obtained by patient interview and chart abstraction |
Demonstration that outcome of interest was not present at start of study | Low risk | Controlled for pre‐operative non‐abdominal infection |
Comparability of cohorts (Controlled for critical factor/other medications) | Low risk | Performed multivariable analysis controlling for preoperative methotrexate and steroids |
Comparability of cohorts (Controlled for additional factor) | Low risk | Controlled for multiple other factors including age, BMI, gender and comorbid disease |
Assessment of outcome | Low risk | Prospective database. Data obtained by patient interview and chart abstraction |
Was follow‐up long enough for outcomes to occur | Low risk | 30 days |
Adequacy of follow up of cohorts | Unclear risk | Authors did not comment whether any patients were lost to follow up |